146 related articles for article (PubMed ID: 30358100)
1. EDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus.
Ugarte-Berzal E; Martens E; Boon L; Vandooren J; Blockmans D; Proost P; Opdenakker G
J Cell Mol Med; 2019 Jan; 23(1):576-585. PubMed ID: 30358100
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
[TBL] [Abstract][Full Text] [Related]
4. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Faber-Elmann A; Sthoeger Z; Tcherniack A; Dayan M; Mozes E
Clin Exp Immunol; 2002 Feb; 127(2):393-8. PubMed ID: 11876767
[TBL] [Abstract][Full Text] [Related]
5. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
6. MMP-2 and MMP-9 in Human Peripheral Blood: Optimizing Gelatinase Calibrator for Degradome Research and Discovering a Novel Gelatinolytic Enzyme.
Ligi D; Maniscalco R; Mannello F
J Proteome Res; 2020 Jan; 19(1):525-536. PubMed ID: 31612719
[TBL] [Abstract][Full Text] [Related]
7. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
Lockshin MD; Qamar T; Redecha P; Harpel PC
Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
[TBL] [Abstract][Full Text] [Related]
8. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
[TBL] [Abstract][Full Text] [Related]
9. In vitro stimulation of C1s proteolytic activities by C1s-presenting autoantibodies from patients with systemic lupus erythematosus.
He S; Lin YL
J Immunol; 1998 May; 160(9):4641-7. PubMed ID: 9574573
[TBL] [Abstract][Full Text] [Related]
10. MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
Ugarte-Berzal E; Boon L; Martens E; Rybakin V; Blockmans D; Vandooren J; Proost P; Opdenakker G
Front Immunol; 2019; 10():538. PubMed ID: 30967870
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
[TBL] [Abstract][Full Text] [Related]
12. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity.
Ertugrul G; Keles D; Oktay G; Aktan S
Arch Dermatol Res; 2018 Mar; 310(2):173-179. PubMed ID: 29349515
[TBL] [Abstract][Full Text] [Related]
14. Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
Mao YM; Wang S; Zhao CN; Wu Q; Dan YL; Guan SY; Lv TT; Liu LN; Wang P; Pan HF
Curr Pharm Des; 2018; 24(16):1780-1787. PubMed ID: 29879882
[TBL] [Abstract][Full Text] [Related]
15. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
16. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
17. A versatile assay for gelatinases using succinylated gelatin.
Baragi VM; Shaw BJ; Renkiewicz RR; Kuipers PJ; Welgus HG; Mathrubutham M; Cohen JR; Rao SK
Matrix Biol; 2000 Jul; 19(3):267-73. PubMed ID: 10936451
[TBL] [Abstract][Full Text] [Related]
18. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
[TBL] [Abstract][Full Text] [Related]
19. Effects of anticoagulants on the activity of gelatinases.
Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
[TBL] [Abstract][Full Text] [Related]
20. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
